Navigation Links
Transcept Pharmaceuticals to Report First Quarter 2009 Results
Date:5/5/2009

RICHMOND, Calif., May 5 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will report results for its first quarter 2009 on Wednesday, May 13, 2009, after market close.

A conference call to review the results will begin at 5:00 p.m. ET (2:00 p.m. PT) on May 13, 2009 and will be hosted by Glenn A. Oclassen, President & Chief Executive Officer and Thomas P. Soloway, Senior Vice President & Chief Financial Officer.

To participate in the conference call, please dial 877-856-1965 (USA) or 719-325-4809 (International). In addition, a dial-up replay of the conference call will be available from May 13, 2009 at 8:00 p.m. ET (5:00 p.m. PT) through May 27, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International), Replay Passcode: 4401678.

A live webcast of the call will also be available from the Investors section on the corporate web site at www.transcept.com. A webcast replay can be accessed on the corporate web site beginning May 13, 2009 at the same time as the conference call and will remain on the site through May 27, 2009.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. On January 30, 2009, Transcept completed a merger with Novacea, Inc. As part of the transaction, Novacea changed its name to "Transcept Pharmaceuticals, Inc." and its NASDAQ ticker symbol to "TSPT." The combined company res
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the Cowen and Company 35 th Annual Health ... Eastern time from the Boston Marriott Copley Place. A live ... . A replay will be available approximately one hour after ...
(Date:2/26/2015)... 26, 2015  Unetixs Vascular Inc, the ... physiologic testing solutions, today announced a partnership ... highly innovative medical imaging company that invented ... SuperSonic Imagine,s technology to more customers in ... Aixplorer Ultrasound System combines exceptional image quality ...
(Date:2/26/2015)... Cyberonics, Inc. (NASDAQ: CYBX ) today announced results ... highlights 1 Operating results for the third quarter of fiscal ... other achievements include: , Worldwide net sales of $72.1 ... , U.S. net sales reached $57.6 million, an increase of ... the single country order, international sales increased by 18% on ...
Breaking Medicine Technology:MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3Unetixs Vascular Announces Partnership with SuperSonic Imagine 2Unetixs Vascular Announces Partnership with SuperSonic Imagine 3Cyberonics Reports Fiscal 2015 Third Quarter Results 2Cyberonics Reports Fiscal 2015 Third Quarter Results 3Cyberonics Reports Fiscal 2015 Third Quarter Results 4Cyberonics Reports Fiscal 2015 Third Quarter Results 5Cyberonics Reports Fiscal 2015 Third Quarter Results 6Cyberonics Reports Fiscal 2015 Third Quarter Results 7Cyberonics Reports Fiscal 2015 Third Quarter Results 8Cyberonics Reports Fiscal 2015 Third Quarter Results 9Cyberonics Reports Fiscal 2015 Third Quarter Results 10Cyberonics Reports Fiscal 2015 Third Quarter Results 11Cyberonics Reports Fiscal 2015 Third Quarter Results 12Cyberonics Reports Fiscal 2015 Third Quarter Results 13Cyberonics Reports Fiscal 2015 Third Quarter Results 14Cyberonics Reports Fiscal 2015 Third Quarter Results 15Cyberonics Reports Fiscal 2015 Third Quarter Results 16Cyberonics Reports Fiscal 2015 Third Quarter Results 17Cyberonics Reports Fiscal 2015 Third Quarter Results 18Cyberonics Reports Fiscal 2015 Third Quarter Results 19
(Date:2/26/2015)... 26, 2015 SpendWell Health, an ... launch to its first customer today, opening its ... covered dependents. , SpendWell delivers the next ... combining real-time price transparency with e-commerce. SpendWell’s unique ... routine health care services and allows shoppers to ...
(Date:2/26/2015)... February 26, 2015 Participants in ... What’s Working? What’s Not? What’s New? ,” will ... programs to achieve strong outcomes for duals-plan members ... happening in the implementation phase of programs for ... made? Which ones need to be implemented in ...
(Date:2/26/2015)... Falls Church, VA (PRWEB) February 26, 2015 ... Medical Devices:, Understanding the FDA’s Position and Best ... April 14-15, 2015 – Bethesda, MD, http://www.fdanews.com/SoftwareAndCybersecurity ... renowned expert Fubin Wu — has been specifically ... to achieve compliance and effectively assure medical device ...
(Date:2/26/2015)... Eating disorders are serious, life-threatening ... In response to emerging research regarding eating disorders ... National Eating Disorders Awareness Week, the Society for ... recommendations for the medical management of restrictive eating ... new approach to assessing the degree of malnutrition ...
(Date:2/26/2015)... February 26, 2015 Body Well Therapy, a ... years of delivering high quality mobile massage services ... other regions across the United States. The company has experienced ... pivotal year as it sets its sights on additional major ... chair massage services. , “We’ve come a long way since ...
Breaking Medicine News(10 mins):Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 3
... three other scientists will receive The Gairdner International Awards, ... their exemplary// research on RNAs, cell motility and hormones. ... Toronto. ,John Dirks, president of the Gairdner ... our understanding of our cells with major ramifications for ...
... Fish oil has numerous health benefits and is being touted ... its honour is welcome.Nicolas G. Bazan, MD, PhD, Boyd Professor// ... LSU Health Sciences Centre in New Orleans, in a paper ... fish oil play in protecting cells in the retina from ...
... at the University of Illinois at Chicago in collaboration ... the structure of an enzyme in the virus that ... have detailed these findings in the March 27 issue ... hope that this could form a new drug target ...
... the effect of tiny nanoparticles on the health of ... traffic exhaust and are also used in making household ... The scientists will assess if these particles damage liver ... 80,000 times smaller than the width of a human ...
... the Vagisil Women's Health CenterSM conducted a survey on feminine ... women are taking active roles in their own feminine health ... aged 18 and older (63 percent) report that they go ... gynecologist, 61 percent say they "always" go for their annual ...
... overseas doctors in Britain are alarmed as new rules ... before they can work// in hospitals of the National ... doctors from the Indian subcontinent who could suddenly ... if there are no local doctors available the first preference ...
Cached Medicine News:Health News:Women aware of “feminine health” : their attitud 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple, intuitive ...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... supply, with temperature probe, 100-120 and 220-240 V, ... mA, and 400 W. The temperature probe is ... 90 degrees C during electrophoresis. Built-in infrared capability ... instructions are provided. Dimensions are 27.5 x 34 ...
Medicine Products: